Beat The Denominator

Investors should consider Hims & Hers Health (HIMS) as a high-growth opportunity, with the stock currently viewed as undervalued following recent market volatility. The company is projected to see significant revenue growth of up to 33% by 2026, bolstered by the Eucalyptus acquisition and a robust subscription model for GLP-1 weight loss treatments. While legal battles with Novo Nordisk (NVO) persist, the impact is expected to be minimal until at least 2029, providing a long runway for current operations. Diversification into new peptides like BPC-157 offers a secondary growth catalyst that protects against potential shifts in the weight loss market. Monitor the FDA approval of Eli Lilly’s (LLY) Retatrutide, as this next-generation drug may eventually disrupt the demand for current compounded semaglutide offerings.

Bitcoin (BTC) is increasingly acting as a "risk-off" safe haven alongside gold, with strong institutional support established around the $67,000 level. Investors seeking high-growth exposure to this trend should consider MicroStrategy (MSTR), which uses its premium share price to aggressively accumulate more Bitcoin. For those prioritizing income, STRC offers an attractive 11% dividend increase and is currently in a high-growth phase as it raises capital above its critical $100 price threshold. Monitor the rapid growth of the APYX stablecoin, as its rising Total Value Locked signals increasing adoption of the broader Bitcoin credit ecosystem. This "Bitcoin Credit Revolution" presents a unique opportunity to move beyond simple holding and into yield-bearing instruments and decentralized finance.

Investors should consider MicroStrategy (MSTR) as a core holding due to its aggressive Bitcoin accumulation and expansion into European markets via new Exchange Traded Products. A high-conviction opportunity exists in Stretch (STRC), which recently increased its yield to 11.5%, a move expected to drive the asset to trade at par value consistently. International investors can capture even higher decentralized yields through the Apex stablecoin, which currently offers approximately 67% APY as it bridges capital into the STRC ecosystem. While Bitcoin (BTC) remains resilient, you should monitor oil prices and Middle East geopolitical tensions as the primary short-term risks to this bullish thesis. Look toward March for a broader macro recovery as the market begins pricing in a transition to a new Federal Reserve Chair.

Investors should view Bitcoin (BTC) as a resilient "risk-off" asset following its rapid V-shaped recovery to the $65,000 range despite geopolitical tensions. BTC remains a high-conviction long-term hold due to its fixed supply of 21 million and its unique status as a portable, unseizable asset during global conflicts. For immediate yield, the Stacks (STX) ecosystem offers a time-sensitive "gold rush" opportunity with yields up to 300% APY on the new APYUSD stablecoin protocol. Monitor MicroStrategy (MSTR) as a strategic proxy for Bitcoin, as it is expected to decouple from traditional software stocks and trade based on its digital asset holdings. Avoid over-exposure to physical commodities like Oil that face supply chain blockades, favoring "thermodynamically sound" digital protocols instead.

Investors should consider MicroStrategy (MSTR) as it shows significant relative strength against Bitcoin (BTC), currently trading at a high premium with a Market Net Asset Value of 1.22. For those seeking a yield-bearing alternative to traditional money market accounts, the MSTZ ("Stretch") instrument has cleared the psychological $100 level and is expanding into European markets and corporate treasuries. The current market sell-off has created potential overreaction entries in high-growth names like SoFi (SOFI) and Eos Energy (EOSE), which have seen massive price declines despite stable fundamentals. Specifically, EOSE may be an aggressive value play after being "halved" post-earnings, as the underlying business outlook remains intact. Monitor MSTR's active capital raises as a signal of continued BTC accumulation, which reinforces its position as a leveraged play on the digital asset's recovery.

Investors should view the current market rotation into defensive "value traps" like Walmart (WMT) and Coca-Cola (KO) as a buying opportunity for high-growth innovation leaders. NVIDIA (NVDA) remains the highest conviction long-term hold, as its fundamental AI growth far outweighs the perceived safety of government bonds. Bitcoin (BTC) is the primary hedge against inevitable currency debasement, serving as a "scarcity play" to protect wealth as the national debt increases. Look for efficiency-driven gains in Block (SQ) and PayPal (PYPL), specifically targeting companies using AI to aggressively reduce headcount and boost margins. Avoid long-term U.S. Treasuries, which are viewed as "return-free risk," and instead focus on Amazon (AMZN) and Tesla (TSLA) to capture the 30%+ revenue growth required to outpace inflation.

The recent 5% dip in NVIDIA (NVDA) is a prime buying opportunity, as the stock remains one of the cheapest high-growth plays in the Magnificent 7 ahead of the upcoming GTC conference and Ruben product launch. Zeta Global (ZETA) offers a high-conviction entry into AI-driven marketing, trading at a significant valuation discount despite guidance for 35% revenue growth through 2026. In the Buy Now, Pay Later sector, Sezzle (SEZL) continues to outperform traditional credit models, though investors may find better value in Klarna following its recent drawdown. Avoid "catching the falling knife" with Oddity Tech (ODD), as its growth thesis has collapsed; look to Hims & Hers (HIMS) for a more stable alternative in the direct-to-consumer space. For healthcare exposure, maintain a cautious Hold on TransMedix Group (TMDX), as slowing growth and long-term disruption from United Therapeutics (UTHR) limit its immediate upside.

With market sentiment in "extreme fear," now could be a favorable time for long-term investors to accumulate Bitcoin (BTC). For a leveraged investment, consider MicroStrategy (MSTR), which is presented as a buying opportunity on its recent dip. European investors seeking high yield can look into the new Bitcoin-backed "Stretch" ETP, trading under the ticker STRCNA on the Euronext Amsterdam exchange. Significant new demand for this product is also expected from DeFi integrations and corporate treasury adoption. Finally, fundamentally strong companies like Nvidia (NVDA) may be undervalued after being sold off with the broader market despite strong earnings.

A significant opportunity may exist in MicroStrategy's debt instruments like "strife" and "stride," which could potentially double in price to the $160-$200 range on a market "re-rating." This trade is based on the thesis that debt backed by a hard digital asset like Bitcoin will be valued more highly. The underlying asset, Bitcoin (BTC), also has a near-term bullish catalyst as the CME moves to 24/7 trading around May 29th. For investors seeking a simpler, leveraged bet on Bitcoin, MicroStrategy (MSTR) stock offers amplified exposure to its price movements. Analysts remain bullish long-term, with some maintaining a Bitcoin price target of ~$200,000 by year-end 2026.

Consider investing in Hims & Hers Health (HIMS), as the market appears to be misinterpreting its growth guidance. The company's official forecast excludes the upcoming Eucalyptus acquisition, which could add an unpriced $200 million in revenue and represent a significant near-term catalyst. The weight loss business is also more resilient than perceived due to its profitable oral medications, reducing reliance on the legally challenged GLP-1 market. For long-term growth in the pharmaceutical space, look at Eli Lilly (LLY), whose pipeline drug retatrutide is considered a potential blockbuster that could lead the next generation of weight loss treatments. The ultimate bull case for HIMS is its long-term potential to become a dominant, AI-driven direct-to-consumer healthcare platform.

Consider Hims & Hers (HIMS) as a compelling long-term investment, as the stock appears significantly undervalued relative to its rapid growth. The company is experiencing strong momentum, particularly in its "Hers" segment which is growing 100% year-over-year, and is showing a clear path to profitability with high gross margins. Current financial guidance is viewed as conservative and does not yet include the pending high-growth Eucalyptus acquisition, suggesting potential for a significant revenue beat. With a strong balance sheet and efficient marketing, the company is well-positioned to achieve its long-term revenue goal of $6.5 billion by 2030. Investors may find the current price an attractive entry point by looking past short-term market narratives.

Consider buying Amazon (AMZN), as its stock appears undervalued given its significant growth potential in grocery and Artificial Intelligence. In contrast, Walmart (WMT) may be overvalued as it faces a major long-term competitive threat from Amazon's expansion. Investors should be extremely cautious with telecom stocks like Verizon (VZ) and AT&T (T), which face fundamental disruption from satellite technology within the next 18 to 24 months. For long-term believers, Bitcoin (BTC) trading near $65,000 could present a buying opportunity, as its weakness is tied to broader market sentiment rather than its own fundamentals. Given the indiscriminate sell-off in high-growth stocks, exercising caution across the board is a prudent strategy until market conditions stabilize.

Consider the recent 25% price drop in Klarna (KLAR) as a significant buying opportunity, as the market seems to be misinterpreting its accounting and long-term growth. The "Buy Now, Pay Later" leader is considered undervalued, trading at just 1 times revenue despite a 26% growth rate and its disruption of the massive credit card industry. The recent earnings miss is attributed to conservative accounting rules that front-load potential losses, masking the company's strong underlying performance in revenue and user growth. An investment in KLAR is a high-conviction bet on the BNPL sector's continued takeover of market share from legacy players like American Express (AXP) and Visa (V). Long-term investors can view the stock's 71% decline from its highs as a chance to own a high-growth innovator at a discounted price.

Watch for Nvidia's (NVDA) earnings report this Wednesday evening, as a positive result is seen as a key catalyst that could help the entire market turn positive. Bitcoin (BTC) has two major positive catalysts expected in May, including the nomination of a market-friendly Fed chair and new crypto-friendly legislation. The CME will also begin 24/7 trading for Bitcoin futures on May 29, which is expected to reduce weekend price volatility. Given these potential tailwinds, Bitcoin is viewed as a high-conviction long-term investment for 2030 and beyond. For a leveraged investment on this theme, consider MicroStrategy (MSTR), which is also positioned as a long-term hold.

The sell-off in the cybersecurity and SaaS sectors is viewed as an overreaction, creating a buying opportunity in high-quality companies. The highest conviction investment is Rubrik (RBRK), a leader in cyber resilience that is projected to grow revenue by +36% over the next year. With the stock down significantly from its highs, RBRK is considered cheap relative to peers like CrowdStrike (CRWD). A key catalyst is the upcoming Q1 earnings report around June, where the company may reach profitability and attract significant investor attention. Rubrik is also strategically positioned for long-term growth by expanding its platform to secure enterprise AI agents.

Consider owning hard assets like Bitcoin (BTC) as a long-term hedge against massive government money printing and currency devaluation. Investors can gain exposure directly or through proxies like Bitcoin miners and MicroStrategy (MSTR). The primary catalyst is the expectation of more stimulus and potential tariff refunds, which could fuel inflation. However, be aware that these assets are extremely volatile and sensitive to macroeconomic news. The most important rule in this unpredictable market is to preserve your capital and avoid using excessive leverage.

The most compelling opportunity is Hims & Hers Health (HIMS), which is considered a strong buy following its recent strategic acquisition of Australian telehealth company Eucalyptus. HIMS is viewed as a long-term winner aiming to become a dominant global consumer health platform by disrupting traditional healthcare with its AI-driven model. Similarly, NVIDIA (NVDA) is seen as severely undervalued, as the market has not fully priced in its massive potential in the AI sector. In contrast, legacy businesses like Walgreens (WBA) face an existential threat from these online disruptors and should be avoided. Other major tech stocks like Google (GOOGL) are seen as fairly valued, while Apple (AAPL) is considered a little expensive at current levels.

Consider Tesla (TSLA) as a primary long-term investment for exposure to the emerging humanoid robot industry through its Optimus project. The core thesis is that TSLA is a unique technology company whose future value in robotics and other ventures is currently underestimated by the market. For a higher-risk, value-oriented approach to the same theme, look at Chinese EV maker XPeng (XPEV). Its extremely low valuation, with a price-to-sales ratio around 0.17, is seen as compensation for the geopolitical risks of investing in China. Owning XPEV offers a speculative call option on its own humanoid robot, the 'Iron Bot,' with its core EV business providing a potential valuation floor.

Consider allocating to Bitcoin (BTC) as a primary long-term store of value, viewing its digital scarcity as superior to physical assets like Gold (GLD). For core equity exposure, favor the tech-focused Invesco QQQ Trust (QQQ) over the S&P 500 for its rules-based, innovation-oriented structure. Income-seeking investors could explore MicroStrategy's "Stretch" debt instrument, which offers a high, tax-deferred yield heavily collateralized by Bitcoin. In contrast, traditional safe-haven assets like US Treasury bonds (TLT) are now considered high-risk and should be avoided due to political and fiscal instability.

Consider MicroStrategy (MSTR) as a long-term, leveraged investment in Bitcoin, as the company aggressively uses its stock to acquire more of the cryptocurrency. The company's strategy of selling new MSTR shares to buy Bitcoin is viewed as beneficial for shareholders because the stock trades at a premium to its underlying crypto assets. This immense buying pressure from institutions like MSTR creates a strong long-term bullish case for Bitcoin (BTC) due to a potential supply and demand imbalance. Current market fear and price weakness in Bitcoin should be viewed as a strategic buying opportunity for long-term accumulators. For investors with a long-term horizon into the 2030s, beaten-down innovative growth stocks like Tesla (TSLA) and AMD (AMD) may also present a significant buying opportunity.